[21 October 2013]
Products Affected - Description
Torsemide injection, American Regent
10 mg/mL, 2 mL vial (NDC 00517-0070-10)
10 mg/mL, 5 mL vial (NDC 00517-0071-10)
Reason for the Shortage
- Roche discontinued Demadex injection for business reasons. Demadex tablets are not affected by this shortage.
- Bedford has approval for torsemide injection, but has not yet launched the product.
- American Regent had temporarily suspended distribution of most drug products presentations in April, 2011.
- American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
No presentations are available at this time.
Estimated Resupply Dates
American Regent has torsemide injection on back order and the company cannot estimate a release date.
October 21, 2013; July 16, 2013; May 9, 2013; April 4, 2013; January 14, 2013; November 20, 2012; September 19, 2012; July 25, 2012; May 23, 2012; April 11, 2012; March 29, 2012, University of Utah, Drug Information Service. Copyright 2013, University of Utah, Drug Information Service.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins